Abstract
Liver transplantation may be indicated in patients with GSD type Ia when dietary treatment fails or when hepatic adenomas develop, because they carry a risk of liver cancer or severe intratumoral haemorrhage. Published reports on the results of liver transplantation in patients with GSD Ia include 10 patients and provide little information on long-term outcome. In particular, it is not known whether liver transplantation prevents renal failure due to focal segmental glomerulosclerosis. We report here on 3 patients with GSD Ia in whom liver transplantation was performed at 15, 17 and 23 years of age because of multiple hepatic adenomas in all 3 patients with a fear of malignant transformation, and of poor metabolic balance and severe growth retardationin the youngest one. Renal function was normal in all patients. During the 6–8 years following transplantation, the quality of life has initially greatly improved, with none of the previous dietary restraints and a spectacular increase in height. However, long-term complications included chronic hepatitis C in one patient, gouty attacks in another and focal segmental glomerulosclerosis with progressive renal insufficiency in the third. These results: (1) confirm that liver transplantation restores a normal metabolic balance in patients with GSD Ia, allows catch-up growth and improves the quality of life; (2) suggest that liver transplantation may be considered in teenagers with unresectable multiple adenomas because of a lack of clear-cut criteria to detect malignant transformation early; and (3) suggest that liver transplantation does not prevent focal segmental glomerulosclerosis associated with GSD Ia.
Similar content being viewed by others
References
Baker L, Dahlem S, Goldfarb S, et al (1989) Hyperfiltration and renal disease in glycogen storage disease type I. Kidney Int 35: 1345-1350.
Ben Hamida M, Hachicha J, Bahloul Z, et al (1995) Cyclosporine-induced hyperuricemia and gout in renal transplants. Transplant Proc 27: 2722-2724.
Bianchi L (1993) Glycogen storage disease type Ia and hepatocellular tumors. Eur J Pediatr 152 (supplement 1): S63-S70.
Borowitz SM, Greene HL, Gay JC, Neblett WW (1987) Comparison of dietary therapy and portocaval shunt in the management of a patient with type Ib glycogen storage disease. J Pediatr Gastroenterol Nutr 6: 635-639.
Brunelle F, Tammam S, Odièvre M, Chaumont P (1984) Liver adenomas in glycogen storage disease in children. Ultrasound and angiographic study. Pediatr Radiol 14: 94-101.
Chen YT, Coleman RA, Scheinman JI, Kolebeck PC, Sidbury JB (1988) Renal disease in type I glycogen storage disease. New Engl J Med 318: 7-11.
Chen YT, Burchell A (1995) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases, 7th edn. New York: McGraw-Hill, 936-965.
Coire CI, Qizilbash AH, Castelli MF (1987) Hepatic adenomata in type Ia glycogen storage disease. Arch Pathol Lab Med 111: 166-169.
Corbeel L, Hue L, Lederer B, et al (1981) Clinical and biochemical findings before and after portocaval shunt in a girl with type Ib glycogen storage disease. Pediatr Res 15: 58-61.
Fernandes J, Chen YT (1995) Glycogen storage diseases. In: Fernandes J, Saudubray JM, Van Den Berghe G, eds. Inborn Metabolic Diseases, 2nd edn. Berlin: Springer-Verlag, 71-85.
Fink AS, Appleman HD, Thompson NW (1985) Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature. Surgery 97: 117-123.
Fraumeni JF, Miller RW, Hill JA (1968) Primary carcinoma of the liver in childhood: an epidemiologic study. J Natl Cancer Inst 40: 1087-1099.
Goldberg T, Slonim AE (1993) Nutrition therapy for hepatic glycogen storage disease. J Am Diet Assoc 93(12): 1423-1430.
Grossman H, Ram PC, Coleman RA et al (1981) Hepatic ultrasonography in type I glycogen storage disease (Von Gierke disease): detection of hepatic adenomas and carcinoma. Radiology 141: 753-756.
Howell RR, Stevenson RE, Ben-Menachen Y et al (1976) Hepatic adenomata with type I glycogen storage disease. JAMA 236: 1481-1484.
Kay RM, Eckardt JJ, Goldstein LI, Busuttil RW (1994) Metastatic hepatocellular carcinoma to bone in a liver transplant patient. Clin Orthop 303: 237-241.
Kirschner BS, Baker AL, Thorp FK (1991) Growth in adulthood after liver transplantation for glycogen storage disease type I. Gastroenterology 101: 238-241.
Labrune P, Trioche P, Duvaltier I, Chevalier P, Odièvre M (1997) Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of literature. J Pediatr Gastroenterol Nutr 24: 276-279.
Lee P, Mather S, Owens C, Leonard J, Dicks-Mireaux C (1994) Hepatic ultrasound findings in glycogen storage disease. Br J Radiol 67: 1062-1066.
Limmer J, Fleig WE, Leupold D, Bittner R, Dischnueit H, Berger HG (1988) Hepatocellular carcinoma in type I glycogen storage disease. Hepatology 8: 531-537.
Malatack JJ, Iwatsuki S, Gartner JC et al (1983) Liver transplantation for type I glycogen storage disease. Lancet i: 1073-1075.
Martinez Ibanez V, Margarit C, Tormo R, et al (1987) Liver transplantation in metabolic diseases: report of five pediatric cases. Transplant Proc 19: 3803-3804.
Miller JH, Gates GF, Landing BH, Kogut MD, Roe TF (1978) Scintigraphic abnormalities in glycogen storage disease. J Nucl Med 19: 354-358.
Parker P, Burr I, Slonim A, Ghishan FK, Greene H (1981) Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy. Gastroenterology 81: 534-536.
Poe R, Snover (1988) Adenomas in glycogen storage disease type I. Two cases with unusual histologic features. Am J Surg Pathol 12: 477-483.
Reid CJD, Hebert D (1996) Acute renal failure complicating liver transplantation in twin sisters with glycogen storage disease type Ia. Transplant Proc 28: 3629-3631.
Rosh JR, Collins J, Groisman GM, et al (1995) Management of hepatic adenoma in glycogen storage disease Ia. J Pediatr Gastroenterol Nutr 20: 225-228.
Selby R, Starzl TE, Yunis E, et al (1993) Liver transplantation for type I and type IV glycogen storage disease. Eur J Pediatr 152(supplement 1): S71-S76.
Smit GPA (1993) The long-term outcome of patients with glycogen storage disease type Ia. Eur J Pediatr 152(supplement 1): S52-S55.
Sokal EM, Lopez Silvarrey A, Buts JP, Otte JB (1993) Orthotopic liver transplantation for type I glycogenosis unresponsive to medical therapy. J Pediatr Gastroenterol Nutr 16: 463-467.
Solez K, Racusen LC, Mihatsch M (1996) Nephrotoxicity of cyclosporine and newer immunosuppressive agents. In: Solez K, Racusen LC, Billingham ME, eds. Solid Organ Transplant Rejection. New York: Marcel Dekker, 588-607.
Talente GM, Coleman RA, Alter C et al (1994) Glycogen storage disease in adults. Ann Intern Med 120: 218-226.
Williams JC (1986) Nutritional goals in glycogen storage disease. N Engl J Med 314: 709-710.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Faivre, L., Houssin, D., Valayer, J. et al. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. J Inherit Metab Dis 22, 723–732 (1999). https://doi.org/10.1023/A:1005544117285
Issue Date:
DOI: https://doi.org/10.1023/A:1005544117285